Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Atlantic's sulfated cyclodextrins effective in preclinical models of restenosis

Oct. 21, 1997

P&G agrees to outlicense antiarrhythmic drug

Oct. 21, 1997

CPC-111 reduces pain of sickle cell crises in phase II

Oct. 21, 1997

Andrx's Diltia XT approved and launched in U.S.

Oct. 20, 1997

Effects of 5-HT, TxA2 and their antagonists on restenosis

Oct. 20, 1997

Clinical results reported for 546C88 in septic shock

Oct. 20, 1997

Draflazine: a potential cardioprotectant with a novel mechanism of action

Oct. 17, 1997

Alpha1-antichymotrypsin analogues described in patent literature

Oct. 17, 1997

Do calcium channel blockers increase risk of cancer?

Oct. 16, 1997

Takeda's Blopress approved in EC

Oct. 16, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...